Abstract: Nanodiamonds having a positive ?-potential of at least 1 mV for use in sequestration of at least one FGF family member in organisms in vivo and in vitro. It has been found that nanodiamonds with a positive ?-potential show an extremely strong and selective binding to FGF family members, thus leading to their usability in the treatment of diseases related to aberrant FGF-FGFR signalling and/or interaction.
Type:
Grant
Filed:
March 26, 2019
Date of Patent:
September 5, 2023
Assignees:
USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I, MASARYKOVA UNIVERZITA, FAKULTNI NEMOCNICE U SV, ANNY V BRNE
Inventors:
Petr Cigler, Lukas Balek, Jan Havlik, Pavel Krejci, Lukas Trantirek, Silvie Trantirkova
Abstract: Nanodiamonds having a positive ?-potential of at least 1 mV for use in sequestration of at least one FGF family member in organisms in vivo and in vitro. It has been found that nanodiamonds with a positive ?-potential show an extremely strong and selective binding to FGF family members, thus leading to their usability in the treatment of diseases related to aberrant FGF-FGFR signalling and/or interaction.
Type:
Application
Filed:
March 26, 2019
Publication date:
January 21, 2021
Applicants:
USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I., MASARYKOVA UNIVERZITA, FAKULTNI NEMOCNICE U SV. ANNY V BRNE
Inventors:
Petr CIGLER, Lukas BALEK, Jan HAVLIK, Pavel KREJCI, Lukas TRANTIREK, Silvie TRANTIRKOVA
Abstract: A method of measuring and analyzing the ultra high frequency EKG is performed by measuring the EKG within the frequency range above 250 Hz with a dynamic range of at least 100 dB. In the UHF EKG signal positions of Rm of R wave in QRS complex of EKG are detected on the time axis and the EKG signal is converted to amplitude or power envelopes, the amplitude or power envelopes frequency range is anywhere within the limits from 0.2 Hz to at least 500 Hz. From these envelopes the amplitude and time numerical parameters that describe the myocardium depolarization inhomogeneity and electric myocardium dyssynchrony are determined, and these parameters are used for selecting the patients for multi-chamber stimulators implementation and optimization of their setting.
Type:
Grant
Filed:
December 19, 2014
Date of Patent:
April 24, 2018
Assignees:
USTAV PRISTROJOVE TECHNIKY AV CR, v.i.i., FAKULTNI NEMOCNICE U SV. ANNY V BRNE, M & I, SPOL. S.R.O.
Inventors:
Pavel Jurak, Josef Halamek, Vlastimil Vondra, Ivo Viscor, Petr Klimes, Filip Plesinger, Pavel Leinveber, Petr Vesely, Tereza Reichlova, Josef Sumbera, Jaroslav Meluzin, Karel Zeman, Miroslav Novak, Jolana Lipoldova, Michal Kuna